| Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022 A Antinori, V Mazzotta, S Vita, F Carletti, D Tacconi, LE Lapini, ... Eurosurveillance 27 (22), 2200421, 2022 | 570 | 2022 |
| Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding D Lapa, F Carletti, V Mazzotta, G Matusali, C Pinnetti, S Meschi, ... The Lancet Infectious Diseases 22 (9), 1267-1269, 2022 | 212 | 2022 |
| 2019-novel coronavirus severe adult respiratory distress syndrome in two cases in Italy: an uncommon radiological presentation F Albarello, E Pianura, F Di Stefano, M Cristofaro, A Petrone, L Marchioni, ... International Journal of Infectious Diseases 93, 192-197, 2020 | 209 | 2020 |
| Humoral-and T-cell–specific immune responses to SARS-CoV-2 mRNA vaccination in patients with MS using different disease-modifying therapies C Tortorella, A Aiello, C Gasperini, C Agrati, C Castilletti, S Ruggieri, ... Neurology 98 (5), e541-e554, 2022 | 155 | 2022 |
| Increase in tuberculosis diagnostic delay during first wave of the COVID-19 pandemic: data from an Italian infectious disease referral hospital F Di Gennaro, G Gualano, L Timelli, P Vittozzi, V Di Bari, R Libertone, ... Antibiotics 10 (3), 272, 2021 | 92 | 2021 |
| Humoral and cellular immune response elicited by mRNA vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in people living with human … A Antinori, S Cicalini, S Meschi, V Bordoni, P Lorenzini, A Vergori, ... Clinical Infectious Diseases 75 (1), e552-e563, 2022 | 83 | 2022 |
| Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study C Agrati, A Cossarizza, V Mazzotta, G Grassi, R Casetti, S De Biasi, ... The Lancet Infectious Diseases 23 (3), 320-330, 2023 | 81 | 2023 |
| Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV A Vergori, A Cozzi Lepri, S Cicalini, G Matusali, V Bordoni, S Lanini, ... Nature Communications 13 (1), 4922, 2022 | 78 | 2022 |
| Efficacy of anti-retraction devices in preventing bacterial contamination of dental unit water lines F Berlutti, L Testarelli, F Vaia, M De Luca, G Dolci Journal of dentistry 31 (2), 105-110, 2003 | 67 | 2003 |
| Coordinate induction of humoral and spike specific T-cell response in a cohort of Italian health care workers receiving BNT162b2 mRNA vaccine C Agrati, C Castilletti, D Goletti, S Meschi, A Sacchi, G Matusali, V Bordoni, ... Microorganisms 9 (6), 1315, 2021 | 63 | 2021 |
| COVID‐19 in people living with HIV: clinical implications of dynamics of the immune response to SARS‐CoV‐2 A Mondi, E Cimini, F Colavita, S Cicalini, C Pinnetti, G Matusali, R Casetti, ... Journal of medical virology 93 (3), 1796-1804, 2021 | 62 | 2021 |
| Kinetics of the B-and T-cell immune responses after 6 months from SARS-CoV-2 mRNA vaccination in patients with rheumatoid arthritis C Farroni, A Picchianti-Diamanti, A Aiello, E Nicastri, B Laganą, C Agrati, ... Frontiers in immunology 13, 846753, 2022 | 47 | 2022 |
| Ocular involvement in monkeypox: description of an unusual presentation during the current outbreak V Mazzotta, A Mondi, F Carletti, F Baldini, R Santoro, S Meschi, ... The Journal of Infection 85 (5), 573, 2022 | 44 | 2022 |
| Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia M Camici, P Zuppi, P Lorenzini, L Scarnecchia, C Pinnetti, S Cicalini, ... International Journal of Infectious Diseases 108, 244-251, 2021 | 44 | 2021 |
| Coordinated cellular and humoral immune responses after two‐dose SARS‐CoV2 mRNA vaccination in liver transplant recipients G D’Offizi, C Agrati, U Visco‐Comandini, C Castilletti, V Puro, P Piccolo, ... Liver International 42 (1), 180-186, 2022 | 39 | 2022 |
| Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with … A Antinori, S Cicalini, S Meschi, V Bordoni, P Lorenzini, A Vergori, ... Clinical Infectious Diseases, 2022 | 35 | 2022 |
| COVID-19 Rapid antigen test as screening strategy at points of entry: experience in Lazio region, central Italy, August–October 2020 F Colavita, F Vairo, S Meschi, MB Valli, E Lalle, C Castilletti, D Fusco, ... Biomolecules 11 (3), 425, 2021 | 33 | 2021 |
| Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine C Agrati, C Castilletti, D Goletti, A Sacchi, V Bordoni, D Mariotti, S Notari, ... Scientific Reports 12 (1), 6687, 2022 | 32 | 2022 |
| Retention of neutralizing response against SARS-CoV-2 omicron variant in sputnik V-Vaccinated individuals D Lapa, DM Grousova, G Matusali, S Meschi, F Colavita, A Bettini, ... Vaccines 10 (5), 817, 2022 | 29 | 2022 |
| Monkeypox virus in human body sites and fluids: evidence for transmission F Colavita, A Antinori, E Nicastri, D Focosi, E Girardi, F Vaia, F Maggi The Lancet Infectious diseases 23 (1), 6-8, 2023 | 28 | 2023 |
Enrico GirardiDirector Epidemiology, INMI Spallanzani, Rome, ItalyVerified email at inmi.it
